Suicide by Means of Opioid Overdose in Patients with Chronic Pain

Current Pain and Headache Reports

Volumn 18, Issue 11, 2014, Pages

  Madadi, Parvaz ^a   Persaud, Nav ^b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Chronic pain; Death; Opioid; Suicide

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

CHRONIC PAIN; DEPRESSION; DISTRESS SYNDROME; DRUG FATALITY; DRUG INDICATION; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; HEALTH CARE UTILIZATION; HUMAN; MEDICAL DECISION MAKING; MENTAL HEALTH; MORTALITY; NORTH AMERICA; PATIENT ATTITUDE; PATIENT SAFETY; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SUBSTANCE ABUSE; SUICIDAL IDEATION; SUICIDE; TREATMENT DURATION; CLINICAL PRACTICE; COMPLICATION; EPIDEMIOLOGY; OPIOID-RELATED DISORDERS; PATIENT SELECTION; PRACTICE GUIDELINE; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; CHRONIC PAIN; DEPRESSION; DRUG OVERDOSE; DRUG PRESCRIPTIONS; HUMANS; NORTH AMERICA; OPIOID-RELATED DISORDERS; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SUICIDE;

EID: 84920901483     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-014-0460-1     Document Type: Review

References (36)

1. Fischer B, Jones W, Urbanoski K, Skinner R, Rehm J. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011. Drug Alcohol Rev. 2014;33:19–26.
2. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;17:686–91.
3. Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, et al. Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q. 2011;14:22–4.
4. Jann M, Kennedy WK, Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract. 2014;27:5–16.
5. Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. Canada: National Opioid Use Guideline Group (NOUGG); 2010 [Accessed 06 Aug 2014]. Available at: http://nationalpaincentre.mcmaster.ca/opioid/.
6. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–30.
7. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminaryvalidation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–42.
8. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9:360–72.
9. Furlan AD, Reardon R, Salach L. The opioid manager: a point-of-care tool to facilitate the use of the Canadian Opioid Guideline. J Opioid Manag. 2012;8:57–61.
10. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613–20.
11. Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305:1346–7.
12. Madadi P, Hildebrandt D, Lauwers AE, Koren G. Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada. PLoS ONE. 2013;8:e60600.
13. Siegler A, Tuazon E, Bradley O’Brien D, Paone D. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk. Int J Drug Policy. 2014;25:569–74.
14. Johnson EM, Lanier WA, Merrill RM, Crook J, Porucznik CA, Rolfs RT, et al. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009. J Gen Intern Med. 2013;28:522–9.
15. Piercefield E, Archer P, Kemp P, Mallonee S. Increase in unintentional medication overdose deaths: Oklahoma, 1994-2006. Am J Prev Med. 2010;39:357–63.
16. Centers for Disease Control and Prevention (CDC). Drug overdose deaths—Florida, 2003-2009. Morb Mortal Wkly Rep. 2011;60:869–72.
17. Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13:87–95.
18. Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses - a U.S. epidemic. Morb Mortal Wkly Rep. 2012;61:10–3.
19. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009;181:891–6.
20. Maine Legislature; 126th Session. An act to address preventable deaths from drug overdose. Accessed 06 Aug 2014. Available at: www.mainelegislature.org/legis/bills/bills_126th/billtexts/HP120901.asp.
21. Office of the Chief Coroner Report for 2009–2011. Accessed 31 July 2014. Available at: http://www.mcscs.jus.gov.on.ca/stellent/groups/public/@mcscs/@www/@com/documents/webasset/ec161620.pdf.
22. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657–9.
23. Sinyor M, Howlett A, Cheung AH, Schaffer A. Substances used in completed suicide by overdose in Toronto: an observational study of coroner’s data. Can J Psychiatry. 2012;57:184–91. This article contains an overview of common substances used in completed suicides and offers a recommendation related to prescribing these substances to at-risk patients.
24. Centers for Disease Control and Prevention (CDC). Toxicology testing and results for suicide victims—13 states, 2004. Morb Mortal Wkly Rep. 2006;55:1245–8.
25. Shields LB, Hunsaker DM, Hunsaker III JC, Ward MK. Toxicologic findings in suicide: a 10-year retrospective review of Kentucky medical examiner cases. Am J Forensic Med Pathol. 2006;27:106–12.
26. Hassett AL, Aquino JK, Ilgen MA. The risk of suicide mortality in chronic pain patients. Curr Pain Headache Rep. 2014;18:436.
27. Tang NK, Crane C. Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med. 2006;36:575–86.
28. Cheatle MD, Wasser T, Foster C, Olugbodi A, Bryan J. Prevalence of suicidal ideation in patients with chronic non-cancer pain referred to a behaviorally based pain program. Pain Phys. 2014;17:E359–67.
29. Ilgen MA, Kleinberg F, Ignacio RV, Bohnert AS, Valenstein M, McCarthy JF, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry. 2013;70:692–7. This article identifies specific pain conditions associated with the greatest risk of suicide after controlling for concurrent psychiatric diagnoses.
30. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31:564–70.
31. Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119:95–103.
32. Haibach JP, Beehler GP, Dollar KM, Finnell DS. Moving toward integrated behavioral intervention for treating multi-morbidity among chronic pain, depression, and substance-use disorders in primary care. Med Care. 2014;52:322–7.
33. Bohnert AS, Roeder KM, Ilgen MA. Unintentional overdose and suicide amongst substance abusers: a review of overlap and risk factors. Drug Alcohol Depend. 2010;110:183–92.
34. Kuramoto SJ, Chilcoat HD, Ko J, Martins SS. Suicidal ideation and suicide attempt across stages of nonmedical prescription opioid use and presence of prescription opioid disorders among U.S. adults. J Stud Alcohol Drugs. 2012;73:178–84.
35. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1, CD006605.
36. Cheatle MD. Depression, chronic pain, and suicide by overdose: on the edge. Pain Med. 2011;12 Suppl 2:S43–8. A holistic commentary on the intersection of depression, chronic pain, and suicide. This piece also discusses possible mediators of suicidal ideation, risk assessment, mental health screening, and strategies for intervention.